Pregnenolone Test
Short Name: PGS
Also known as: Preimplantation Genetic Testing for Aneuploidy (PGT-A), Comprehensive Chromosome Screening (CCS), Embryo Genetic Screening, IVF Genetic Screening, Embryo Aneuploidy Testing
Pregnenolone Test test available at DNA Labs India for ₹16,380. Uses Next Generation Sequencing (NGS), Comprehensive Chromosome Screening on Embryo Cells (Biopsied Trophectoderm or Blastomere) samples. Results in Sample received by Tuesday 9:00 AM — Report delivered by the following Tuesday (approximately 7–10 working days).. Free home collection in 300+ cities across India.
🩺 Medically Reviewed By
Dr SULOCHANA HEMCHANDRA HOLLA
Consultant Medical Geneticist · Reg: 8532
Last reviewed: September 7, 2026
Overview
The primary purpose of Preimplantation Genetic Screening (PGS) is to evaluate embryos created through IVF for chromosomal abnormalities before they are transferred to the uterus. By identifying euploid (chromosomally normal) embryos, PGS aims to improve implantation success rates, reduce the risk of miscarriage, decrease the chance of conceiving a child with a chromosomal disorder, and minimize the need for multiple IVF cycles. PGS empowers couples and their fertility specialists to make evidence-based decisions about embryo selection, ultimately increasing the likelihood of a healthy live birth.
- Test Code
- 1398
- CPT Code
- 81228
- ICD Code
- Z31.49
- Price
- ₹16,380
- Sample Type
- Embryo Cells (Biopsied Trophectoderm or Blastomere)
- Result Time
- Sample received by Tuesday 9:00 AM — Report delivered by the following Tuesday (approximately 7–10 working days).
- Fasting Required
- No
- Method
- Next Generation Sequencing (NGS), Comprehensive Chromosome Screening
Sample Collection
A duly filled Preimplantation Genetic Screening Consent form (Form 23) is mandatory before sample submission. The fertility clinic must coordinate with DNA Labs India to schedule sample collection and dispatch. Embryo biopsy is performed by a trained embryologist during the IVF cycle, typically at the blastocyst stage (day 5 or 6). Couples are advised to undergo genetic counseling before the procedure to understand the implications, benefits, and limitations of PGS.
Method: Embryo biopsy during IVF cycle (performed by embryologist)
Laboratory Analysis
The embryologist performs a trophectoderm biopsy, removing 5–10 cells from the outer layer of the blastocyst-stage embryo. Biopsied cells are placed into a unique transport tube available from LPL. For each embryo being tested, a separate tube and line submission is required. The embryos may be vitrified (frozen) while results are awaited.
Report Delivery
After biopsy, the embryo is typically vitrified and stored until results are available. Biopsied samples are shipped frozen in special transport containers provided by LPL. PGS results are generally available within 7–10 working days. Genetic counseling is provided upon delivery of results to help interpret findings and plan next steps for embryo transfer.
Timeline: Sample received by Tuesday 9:00 AM — Report delivered by the following Tuesday (approximately 7–10 working days).
Patient Instructions
About This Test
Who Should Get This Test
The primary purpose of Preimplantation Genetic Screening (PGS) is to evaluate embryos created through IVF for chromosomal abnormalities before they are transferred to the uterus. By identifying euploid (chromosomally normal) embryos, PGS aims to improve implantation success rates, reduce the risk of miscarriage, decrease the chance of conceiving a child with a chromosomal disorder, and minimize the need for multiple IVF cycles. PGS empowers couples and their fertility specialists to make evidence-based decisions about embryo selection, ultimately increasing the likelihood of a healthy live birth.
How to Prepare
- Submit biopsied embryo cells in a unique tube available from LPL
- In case of multiple embryos being tested, submit a separate line and tube for each embryo source
- Ship frozen in special transport containers available from LPL
- A duly filled Preimplantation Genetic Screening Consent form (Form 23) is mandatory
- Sample to be collected and dispatched with prior appointment only
- Ensure proper labeling with patient identification and embryo number on each tube
- Maintain cold chain during transport to preserve sample integrity
Doctor's Notes
Reviewed by Dr SULOCHANA HEMCHANDRA HOLLA — MBBS, MD (Medical Genetics) · Reg. No. 8532
"Preimplantation Genetic Screening is a critical advancement in assisted reproductive technology. By screening embryos for chromosomal aneuploidy prior to uterine transfer, PGS significantly improves implantation rates and reduces the likelihood of miscarriage. I recommend PGS for couples with a history of recurrent pregnancy loss, advanced maternal age, or previous failed IVF cycles. It empowers patients to make informed decisions about embryo selection and increases the probability of a healthy live birth. Always discuss with your reproductive medicine specialist whether PGS is appropriate for your individual clinical scenario."
Last medically reviewed: September 7, 2026
Test Parameters & Specifications
Sample Stability
- Missing or incomplete Preimplantation Genetic Screening Consent form (Form 23)
- Sample not shipped in designated LPL transport containers
- Sample received at room temperature without frozen cold chain
- Insufficient number of biopsied cells for analysis
- Mislabeled or unlabeled sample tubes
- Sample without prior appointment confirmation
Understanding Your Results
Euploid (Normal)
The embryo has the correct number of chromosomes (46,XX or 46,XY). This embryo is recommended for transfer as it has the highest probability of resulting in a healthy pregnancy.
Clinical action: Proceed with frozen embryo transfer (FET) cycle as guided by your fertility specialist.
Aneuploid (Abnormal)
The embryo has an abnormal number of chromosomes (e.g., trisomy or monosomy). Transferring an aneuploid embryo carries a high risk of implantation failure, miscarriage, or a child with a chromosomal disorder.
Clinical action: This embryo is generally not recommended for transfer. Discuss options with your fertility specialist.
Mosaic
The embryo contains a mixture of chromosomally normal and abnormal cells. The clinical outcome depends on the type and level of mosaicism detected.
Clinical action: Transfer of mosaic embryos may be considered in select cases when no euploid embryos are available, with thorough genetic counseling and informed consent.
No Result / Inconclusive
The analysis could not produce a clear result due to insufficient DNA, sample degradation, or technical issues.
Clinical action: Re-biopsy of the embryo (if still available) or re-testing may be recommended. Discuss with your fertility team.
Consult your reproductive medicine specialist or genetic counselor if you are planning IVF and have a history of recurrent miscarriages, are of advanced maternal age, have a family history of chromosomal abnormalities or genetic disorders, or have experienced repeated IVF failures. A genetic counselor should also be consulted to discuss PGS results before making decisions about embryo transfer.
Limitations
- ⚠PGS screens for chromosomal number abnormalities but does not detect all single gene disorders unless specifically ordered as PGT-M
- ⚠Mosaicism within an embryo may result in discordance between the biopsy result and the actual chromosomal status of the embryo
- ⚠A euploid result does not guarantee a successful pregnancy or a healthy live birth
- ⚠The test cannot detect structural birth defects, epigenetic disorders, or non-genetic causes of pregnancy loss
- ⚠Biopsy of the embryo carries a small risk of damage to the embryo, though modern techniques minimize this risk
Risks & Considerations
- ●Small risk of embryo damage during biopsy, though modern trophectoderm biopsy techniques have significantly reduced this risk
- ●False positives or false negatives may occur due to mosaicism or technical limitations
- ●Emotional stress associated with receiving abnormal results or inconclusive findings
- ●The biopsy does not alter the embryo's genetic makeup but removes a small number of cells
- ●A normal PGS result does not eliminate all risks of genetic disease or pregnancy complications
Interfering Factors
- ●Embryo quality: Poor-quality embryos may not yield sufficient cells for accurate analysis
- ●Mosaicism: Mixed populations of normal and abnormal cells within an embryo can lead to ambiguous results
- ●Sample handling: Improper storage, shipping, or transport conditions may affect DNA integrity
- ●Contamination: External DNA contamination during biopsy or processing may compromise results
- ●Technical limitations: Very low-level mosaicism may not be detected by current NGS methods
Compare With Similar Tests
| Test | Pregnenolone Test | Preimplantation Genetic Diagnosis (PGD/PGT-M) | Non-Invasive Prenatal Testing (NIPT) | Amniocentesis | Chorionic Villus Sampling (CVS) |
|---|---|---|---|---|---|
| Comparison | Pregnenolone Test | PGD tests for specific known single-gene disorders (e.g., cystic fibrosis, sickle cell disease) in embryos, while PGS screens broadly for chromosomal number abnormalities. | NIPT screens for chromosomal abnormalities in a fetus during pregnancy using maternal blood, whereas PGS screens embryos before implantation during IVF. | Amniocentesis is a prenatal diagnostic test performed during pregnancy (15–20 weeks) to detect chromosomal and genetic abnormalities. PGS is performed before pregnancy, during the IVF process. | CVS is a first-trimester prenatal diagnostic test. Unlike PGS, it is performed after implantation and pregnancy has been established, typically around 10–13 weeks of gestation. |
Frequently Asked Questions
What is Preimplantation Genetic Screening (PGS)?
Who should consider PGS testing?
How is the PGS test performed?
What is the cost of the PGS test at DNA Labs India?
Does PGS guarantee a successful pregnancy?
Is the embryo biopsy procedure safe? Does it harm the embryo?
How long does it take to get PGS results?
Can PGS detect all genetic disorders?
What happens if all my embryos are found to be aneuploid?
Do I need genetic counseling before PGS testing?
Is PGS the same as PGD (Preimplantation Genetic Diagnosis)?
How do I submit my embryo sample for PGS at DNA Labs India?
Related Tests
Y-Chromosome Microdeletion Detection PCR Test
₹8,190CATSPER2 Gene Deafness and male infertility, CATSPER2 related NGS Genetic Test
₹20,000Pre-Implantation Genetic Screening /PGS (per Embryo)
₹12,000Y Chromosome Microdeletion (16 Mutations)
₹8,000NANOS1 Gene Oligo-astheno-teratozoospermia NGS Genetic Test
₹20,000FISH - Sperm Aneuploidy Test
₹10,000Reference Laboratory Services
We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.
Your Data Privacy
Your medical data is protected under Indian law.
✓ Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.
✓ DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.
Book Your Test
Enter your details and we'll connect you within 15 minutes.
